Revumenib – Monotherapy in Patients with KMT2Ar R/R Acute Leukemia


monotherapy; kmt2a; kmt2ar; kmt2a translocation; kmt2a translocated; AUGMENT-101; NCT04065399; relapsed; refractory; all; aml; myeloid; lymphocytic; lymphoblastic